HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program.

Abstract
Classic physiology studies dating to the 1930s demonstrate that moderate or transient glucocorticoid (GC) exposure improves muscle performance. The ergogenic properties of GCs are further evidenced by their surreptitious use as doping agents by endurance athletes and poorly understood efficacy in Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease. A defined molecular basis underlying these performance-enhancing properties of GCs in skeletal muscle remains obscure. Here, we demonstrate that ergogenic effects of GCs are mediated by direct induction of the metabolic transcription factor KLF15, defining a downstream pathway distinct from that resulting in GC-related muscle atrophy. Furthermore, we establish that KLF15 deficiency exacerbates dystrophic severity and muscle GC-KLF15 signaling mediates salutary therapeutic effects in the mdx mouse model of DMD. Thus, although glucocorticoid receptor (GR)-mediated transactivation is often associated with muscle atrophy and other adverse effects of pharmacologic GC administration, our data define a distinct GR-induced gene regulatory pathway that contributes to therapeutic effects of GCs in DMD through proergogenic metabolic programming.
AuthorsAlexander Morrison-Nozik, Priti Anand, Han Zhu, Qiming Duan, Mohamad Sabeh, Domenick A Prosdocimo, Madeleine E Lemieux, Nikolai Nordsborg, Aaron P Russell, Calum A MacRae, Anthony N Gerber, Mukesh K Jain, Saptarsi M Haldar
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 112 Issue 49 Pg. E6780-9 (Dec 08 2015) ISSN: 1091-6490 [Electronic] United States
PMID26598680 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • KLF15 protein, human
  • Kruppel-Like Transcription Factors
  • Nuclear Proteins
  • Receptors, Glucocorticoid
Topics
  • Animals
  • Female
  • Glucocorticoids (pharmacology, therapeutic use)
  • Humans
  • Kruppel-Like Transcription Factors (physiology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Skeletal (drug effects, physiopathology)
  • Muscular Dystrophy, Duchenne (drug therapy)
  • Nuclear Proteins (physiology)
  • Receptors, Glucocorticoid (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: